Speciality Chemicals Magazine JUL / AUG 2021 | Page 2

FEATURING : SYNTHETIC SMALL MOLECULES FEATURING SYNTHETIC SMALL MOLECULES FEATURING ::
SYNTHETIC SMALL MOLECULES FEATURING ::
SYNTHETIC SMALL MOLECULES

We Care About Optimizing Scale-up We We Care About for Synthetic Optimizing

Small Molecule API for API Scale-up for Synthetic Small Molecule API

Scope and Scale Scope and Scale Scope and Scale Scope and Scale
3 cGMP facilities with network of scales from 1Kg to 200MT 3 cGMP volumes facilities with network of scales from 1Kg to
3 3200MT cGMP facilities volumes with network of of scales from 1Kg to to
200MT Controlled 3 3 cGMP volumes facilities substance with , network segregated of of scales potent from and
1Kg to to non-potent 200MT Controlled volumes
handling substance capabilities , segregated , flow potent chemistry and , Controlled specialized non-potent substance formulation handling , capabilities , segregated development
, potent flow chemistry and , non-potent Controlled specialized substance handling formulation capabilities , segregated , development , , flow potent chemistry and
, , specialized Specialized non-potent handling formulation chemistries capabilities development such as , MPEG flow , chemistry derivatives , , ,
Nanoparticles specialized Specialized formulation chemistries , ADC payloads development such and as MPEG efficient derivatives purification , Specialized solutions Nanoparticles for chemistries complex , ADC payloads molecules such as as and MPEG efficient derivatives purification , , Nanoparticles Specialized solutions for chemistries , complex , ADC payloads molecules such as and as MPEG efficient derivatives purification
, , solutions Integrated Nanoparticles for and for complex , ADC experienced , payloads molecules process and efficient development purification
, technical solutions Integrated transfer for for and
complex experienced , and molecules process process engineering development teams with , Integrated deep technical experience and transfer experienced in , solving and process complex process engineering API development challenges teams , , with technical under Integrated deep accelerated experience transfer and experienced , , in timelines and solving process process complex engineering development
API challenges teams , with , deep technical under experience accelerated transfer in , in and , solving timelines process complex engineering API challenges teams with under Commercial deep experience accelerated supply in in timelines solving record for complex over 20 API years challenges under Commercial accelerated supply timelines record for over 20 years Commercial supply record for for over 20 20 years Commercial supply record for for over 20 20 years

complex chemistry complex chemistry complex complex chemistry chemistry phase appropriate socutions phase appropriate socutions phase appropriate socutions seamless progress transfer seamless progress transfer seamless progress transfer

Dedication to continuous improvement and Dedication ongoing to capabilities continuous expansion improvement has Dedication to to continuous improvement made Dedication and ongoing us a valuable to to continuous capabilities long-term improvement expansion partner has to and ongoing capabilities expansion has our and made clients ongoing us valuable capabilities long-term expansion partner has to made us valuable long-term partner to to made our clients us a valuable long-term partner to to our clients our For clients more than fifty years , BIOVECTRA has assisted clients For more with than small fifty molecule years , BIOVECTRA projects from has assisted For investigational clients more with than small fifty molecule years , BIOVECTRA , projects from has assisted clients For more investigational with than small fifty
new new molecule years
drug
, ( IND BIOVECTRA
) applications drug ( IND projects ) applications from has through assisted clinical through investigational clients with trials small and commercial clinical trials and new molecule commercial drug IND ( projects
supply , ) ( supply applications from
providing phase-appropriate ) , providing through investigational phase-appropriate trials and new
solutions commercial drug ( IND
. We solutions . supply ) applications
focus delivering We focus , providing
through clinical , on delivering phase-appropriate clinical trials scale and commercial product quantities clinical trial scale product solutions quantities . We supply focus , while providing
addressing scale-up . while on delivering on addressing clinical phase-appropriate requirements scale-up trial requirements scale product solutions
and long-term and quantities . We focus
manufacturing long-term while on manufacturing addressing delivering options scale-up clinical trial that options requirements that scale
address product key cost address key and quantities
of goods cost long-term while
( COGs of goods manufacturing addressing
) targets ( COGs ) options scale-up
. targets that . requirements address key and cost long-term of of goods manufacturing
COGs ( ) targets options . that address key cost of of goods ( COGs ( ) )
Our targets experience . . in a wide variety of complex chemistries Our experience provides in a diverse wide variety route of options complex and is Our another chemistries experience provides in in wide in a diverse variety route of of complex of options and is chemistries Our experience key reason another key provides in a clients wide reason diverse clients variety
rely on rely route of
us on options complex
. Specifically , our ability us . Specifically and is is is , our another chemistries to develop ability to key provides
and develop reason and clients diverse
manufacture manufacture rely route on us options APIs through on us APIs . Specifically and is
both synthetic . through both
, our ability another , synthetic to to key routes develop reason
and to routes and and clients
fermentation manufacture fermentation rely on
, us
sometimes , APIs . Specifically sometimes through both
, our combining synthetic ability to develop the two combining routes the two and and
approaches approaches fermentation manufacture
, allows , allows , sometimes APIs our through clients both
to leverage , our clients to combining synthetic the routes best leverage the the the best two and
of both approaches of fermentation
worlds . both worlds , allows , sometimes , . our clients to to leverage combining the the best two of approaches of both worlds , allows . our clients to to leverage the the best of of both worlds . .
Aligning Our Strengths with Client Needs Aligning Our Strengths with Client Needs Aligning Our Strengths with Client Needs Aligning Fortified Our Supply Strengths Assurance with Client Needs
Supply Fortified Chain Supply Continuity Assurance for Essential Products Fortified Supply Assurance Fortified Supply Chain Supply Continuity Assurance for Essential Products Supply Improved Chain Process Continuity Economics for for Essential Products Supply Chain Continuity for for Essential Products Optimizing Improved Transfer Process from Lab Economics to Manufacturing Floor Improved Process Economics Improved Optimizing Transfer Process from Economics
Lab to Manufacturing Floor Optimizing Transfer from Lab to to Manufacturing Floor Accelerated Optimizing Transfer Speed-to-Market
from Lab Manufacturing Floor Programs Accelerated Aligned Speed-to-Market
Client Timeline Accelerated Speed-to-Market Early Accelerated Programs Phase Aligned Product Speed-to-Market
Production Client Timeline
Programs Early Phase Aligned Product to to Client to Production
Timeline
Early Programs Phase Aligned
Product to Client Production
Timeline Highly Early Phase Skilled Product , Reliable Production
Partner Batch Highly and Skilled Flow Chemistry , Reliable Expertise Partner Highly Skilled , Reliable Partner Managing Highly Batch and Skilled Controlled Flow , Chemistry , Reliable Substances Expertise Partner and Highly Potent API
Batch Managing and Flow Controlled
Chemistry Substances Expertise and Highly Potent API
Managing
Batch and Controlled Flow Chemistry
Substances Expertise and Highly Potent API Managing Controlled Substances and Highly Potent API
For more information , visit us at www . BIOVECTRA . com For more information , visit us at www . BIOVECTRA . com For more information , visit us us at at www BIOVECTRA . com . For more information , visit , us us at at www . BIOVECTRA . . com .